155.Tetta C., Bellomo R., Kellum J. et al. High volume hemofiltration in criticall ill patients: why, when and how. Contrib. Nephrol. 2004; 144: 362 375.
156.Van den Berghe G., Wouters P.J., Bouillon R. et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359 366.
157.Wagner F.W. A classification and treatment program for diabetic, neuropatic and dysvascular foot problems. // In The American Academy of Ortopaedic Surgeons instructional course lectures. St. Louis. Mosby Year Book. 1979. P. 143 165.
158.Warren B.L., Bid A., Singer P. et al: High dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001; 286:1869 1878.
159.Wu L., Holbrook C., Zaborina O. et al. Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA I Lectin
/Adhesin, in the intestinal tract of a stressed host. The role of epithelia cell contact and molecules of the quorum sensing signaling system. //Ann.Surg., 2003. V.238. P.754 764.
